Advertisement
Screener

Intuitive Surgical, Inc. (ISRG) Effective Income Tax Rate Reconciliation, Nondeductible Expense, Charitable Contributions, Amount

2.9 / 5 stars · 51/87 Roast Me

Intuitive Surgical, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Charitable Contributions, Amount

Intuitive Surgical, Inc. (ISRG) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Charitable Contributions, Amount of $30.00 million for the 3-month period ending 2021-12-31, per its 10-K filed 2022-02-03.

Discontinued › Expense Statement › Income Tax

us-gaap:IncomeTaxReconciliationNondeductibleExpenseCharitableContributions · last filed 2022-02-03

  • Intuitive Surgical, Inc. effective income tax rate reconciliation, nondeductible expense, charitable contributions, amount for the quarter ending 2021-12-31 was $30.00M, a 20.00% increase year-over-year.
  • Intuitive Surgical, Inc. effective income tax rate reconciliation, nondeductible expense, charitable contributions, amount for the quarter ending 2021-09-30 was $0.00.
  • Intuitive Surgical, Inc. effective income tax rate reconciliation, nondeductible expense, charitable contributions, amount for the quarter ending 2021-06-30 was $0.00.
  • Intuitive Surgical, Inc. effective income tax rate reconciliation, nondeductible expense, charitable contributions, amount for the quarter ending 2021-03-31 was $0.00.
Period endEffective Income Tax Rate Reconciliation, Nondeductible Expense, Charitable Contributions, Amount 3 monthEffective Income Tax Rate Reconciliation, Nondeductible Expense, Charitable Contributions, Amount 6 monthEffective Income Tax Rate Reconciliation, Nondeductible Expense, Charitable Contributions, Amount 9 monthEffective Income Tax Rate Reconciliation, Nondeductible Expense, Charitable Contributions, Amount 12 month
2021-12-31$30.00M
10-K · filed 2022-02-03
$30.00M
derived: sum of 2 quarters · filed 2022-02-03
$30.00M
derived: sum of 3 quarters · filed 2022-02-03
$30.00M
derived: sum of 4 quarters · filed 2022-02-03
2021-09-30$0.00
10-K · filed 2022-02-03
$0.00
derived: sum of 2 quarters · filed 2022-02-03
$0.00
derived: sum of 3 quarters · filed 2022-02-03
$25.00M
derived: sum of 4 quarters · filed 2022-02-03
2021-06-30$0.00
10-K · filed 2022-02-03
$0.00
derived: sum of 2 quarters · filed 2022-02-03
$25.00M
derived: sum of 3 quarters · filed 2022-02-03
$25.00M
derived: sum of 4 quarters · filed 2022-02-03
2021-03-31$0.00
10-K · filed 2022-02-03
$25.00M
derived: sum of 2 quarters · filed 2022-02-03
$25.00M
derived: sum of 3 quarters · filed 2022-02-03
$25.00M
derived: sum of 4 quarters · filed 2022-02-03
2020-12-31$25.00M
10-K · filed 2022-02-03
$25.00M
derived: sum of 2 quarters · filed 2022-02-03
$25.00M
derived: sum of 3 quarters · filed 2022-02-03
$25.00M
derived: sum of 4 quarters · filed 2022-02-03
2020-09-30$0.00
10-K · filed 2022-02-03
$0.00
derived: sum of 2 quarters · filed 2022-02-03
$0.00
derived: sum of 3 quarters · filed 2022-02-03
$5.00M
derived: sum of 4 quarters · filed 2022-02-03
2020-06-30$0.00
10-K · filed 2022-02-03
$0.00
derived: sum of 2 quarters · filed 2022-02-03
$5.00M
derived: sum of 3 quarters · filed 2022-02-03
$5.00M
derived: sum of 4 quarters · filed 2022-02-03
2020-03-31$0.00
10-K · filed 2022-02-03
$5.00M
derived: sum of 2 quarters · filed 2022-02-03
$5.00M
derived: sum of 3 quarters · filed 2022-02-03
$5.00M
derived: sum of 4 quarters · filed 2022-02-03
2019-12-31$5.00M
10-K · filed 2021-02-10
$5.00M
derived: sum of 2 quarters · filed 2021-02-10
$5.00M
derived: sum of 3 quarters · filed 2021-02-10
$5.00M
derived: sum of 4 quarters · filed 2021-02-10
2019-09-30$0.00
10-K · filed 2021-02-10
$0.00
derived: sum of 2 quarters · filed 2021-02-10
$0.00
derived: sum of 3 quarters · filed 2021-02-10
$25.20M
derived: sum of 4 quarters · filed 2021-02-10
2019-06-30$0.00
10-K · filed 2021-02-10
$0.00
derived: sum of 2 quarters · filed 2021-02-10
$25.20M
derived: sum of 3 quarters · filed 2021-02-10
$25.20M
derived: sum of 4 quarters · filed 2021-02-10
2019-03-31$0.00
10-K · filed 2021-02-10
$25.20M
derived: sum of 2 quarters · filed 2021-02-10
$25.20M
derived: sum of 3 quarters · filed 2021-02-10
$25.20M
derived: sum of 4 quarters · filed 2021-02-10
2018-12-31$25.20M
10-K · filed 2020-02-07
$25.20M
derived: sum of 2 quarters · filed 2020-02-07
$25.20M
derived: sum of 3 quarters · filed 2020-02-07
$25.20M
derived: sum of 4 quarters · filed 2020-02-07
2018-09-30$0.00
10-K · filed 2020-02-07
$0.00
derived: sum of 2 quarters · filed 2020-02-07
$0.00
derived: sum of 3 quarters · filed 2020-02-07
2018-06-30$0.00
10-K · filed 2020-02-07
$0.00
derived: sum of 2 quarters · filed 2020-02-07
2018-03-31$0.00
10-K · filed 2020-02-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
Edwards Lifesciences Corp (EW)United States$49.409B51.96
STERIS plc (STE)Ireland$20.343B25.49
ZIMMER BIOMET HOLDINGS, INC. (ZBH)United States$17.103B20.66
ALIGN TECHNOLOGY INC (ALGN)United States$10.346B29.06
MSA Safety Inc (MSA)United States$7.023B21.47
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81